Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The present study was conducted to find out whether the bioavailability of 10 mg lisinopril
tablets produced by PT Dexa Medica was equivalent to the tablets produced by the innovator
(Zestril® 10 mg, PT Boehringer Ingelheim Indonesia, Indonesia, under license from Astra
Zeneca UK Ltd.)